Donor‐specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report-Reference-Cited by-同舟云学术

Donor‐specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report

Published:2024-01-11 Issue:4 Volume:204 Page:1540-1544
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kunvarjee Binni¹^ORCID,Contreras Yametti Gloria Paz²^ORCID,Blouin Amanda G.³^ORCID,Linder Grace E.³,Borge P. Dayand³,Maryamchik Elena³,Budhai Alexandra³,Gupta Gaurav K.³,Scaradavou Andromachi²^ORCID,Spitzer Barbara G.²,Curran Kevin J.²,Oved Joseph H.²,Harris Andrew C.²,Sharma Akshay⁴,Boelens Jaap Jan²,Cancio Maria I.²^ORCID

Affiliation:

1. Department of Pharmacy Memorial Sloan Kettering Cancer Center New York New York USA

2. Pediatric Bone Marrow Transplant and Cellular Therapies, MSK Kids Memorial Sloan Kettering Cancer Center New York New York USA

3. Department of Pathology and Laboratory Medicine Memorial Sloan Kettering Cancer Center New York New York USA

4. Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research Hospital Memphis Tennessee USA

Funder

National Institutes of Health

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19289

Reference16 articles.

1. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study

2. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation

3. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT

4. Outcomes of patients who underwent treatment for anti‐HLA donor‐specific antibodies before receiving a haploidentical hematopoietic cell transplant

5. Treatment of allosensitized patients receiving allogeneic transplantation

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation;Pediatric Blood & Cancer;2024-09-03

2. Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know;Oncology and Therapy;2024-06-15